These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22435191)

  • 1. Triggers for foot and mouth disease vaccination in the United States.
    Parent KB; Miller GY; Hullinger PJ
    Rev Sci Tech; 2011 Dec; 30(3):789-96. PubMed ID: 22435191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foot-and-mouth disease. Report urges U.K. to vaccinate herds.
    Stone R
    Science; 2002 Jul; 297(5580):319-21. PubMed ID: 12130760
    [No Abstract]   [Full Text] [Related]  

  • 3. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies II: Waiting Periods After Emergency Vaccination in FMD Free Countries.
    Geale DW; Barnett PV; Clarke GW; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):388-406. PubMed ID: 24131661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication of FMD virus.
    Donaldson AI
    Vet Rec; 2006 Apr; 158(16):571-2. PubMed ID: 16632535
    [No Abstract]   [Full Text] [Related]  

  • 5. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies I: Benefits of Higher Potency Vaccines and Associated NSP DIVA Test Systems in Post-Outbreak Surveillance.
    Barnett PV; Geale DW; Clarke G; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):367-87. PubMed ID: 24112127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the impact of vaccination control strategies on a foot and mouth disease outbreak in the Central United States.
    McReynolds SW; Sanderson MW; Reeves A; Hill AE
    Prev Vet Med; 2014 Dec; 117(3-4):487-504. PubMed ID: 25457133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for controlling FMD.
    Vet Rec; 2006 Mar; 158(12):387. PubMed ID: 16565329
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccination against foot-and-mouth disease: the implications for Canada.
    Kahn S; Geale DW; Kitching PR; Bouffard A; Allard DG; Duncan JR
    Can Vet J; 2002 May; 43(5):349-54. PubMed ID: 12001500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing control strategies against foot-and-mouth disease: will vaccination be cost-effective in Denmark?
    Boklund A; Halasa T; Christiansen LE; Enøe C
    Prev Vet Med; 2013 Sep; 111(3-4):206-19. PubMed ID: 23791121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic benefits of targeted response strategies against foot-and-mouth disease in Australia.
    Seitzinger AH; Hafi A; Addai D; Garner G; Bradhurst R; Breed AC; Capon T; Miller C; Pinol J; Tapsuwan S
    Prev Vet Med; 2022 Jul; 204():105636. PubMed ID: 35430444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of vaccines in South American foot-and-mouth disease eradication programmes.
    Saraiva V; Darsie G
    Dev Biol (Basel); 2004; 119():33-40. PubMed ID: 15742616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making a vaccinate-to-live policy a reality in foot-and-mouth disease.
    Mackay D; Parida S; Paton D; Anderson J
    Dev Biol (Basel); 2004; 119():261-6. PubMed ID: 15742637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the benefits of vaccination when used in combination with stamping-out measures against hypothetical introductions of foot-and-mouth disease into New Zealand: a simulation study.
    Sanson RL; Rawdon T; Owen K; Hickey K; van Andel M; Yu ZD
    N Z Vet J; 2017 May; 65(3):124-133. PubMed ID: 27870922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating vaccination strategies to control foot-and-mouth disease: a model comparison study.
    Roche SE; Garner MG; Sanson RL; Cook C; Birch C; Backer JA; Dube C; Patyk KA; Stevenson MA; Yu ZD; Rawdon TG; Gauntlett F
    Epidemiol Infect; 2015 Apr; 143(6):1256-75. PubMed ID: 25078780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-farm eradication of foot-and-mouth disease as an alternative to mass culling.
    Poulin MC; Christianson WT
    Vet Rec; 2006 Apr; 158(14):467-72. PubMed ID: 16603550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological analysis of an outbreak of foot-and-mouth disease (serotype SAT2) on a large dairy farm in Kenya using regular vaccination.
    Lyons NA; Stärk KD; van Maanen C; Thomas SL; Chepkwony EC; Sangula AK; Dulu TD; Fine PE
    Acta Trop; 2015 Mar; 143():103-11. PubMed ID: 25447264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foot-and-mouth disease virus transmission dynamics and persistence in a herd of vaccinated dairy cattle in India.
    Hayer SS; VanderWaal K; Ranjan R; Biswal JK; Subramaniam S; Mohapatra JK; Sharma GK; Rout M; Dash BB; Das B; Prusty BR; Sharma AK; Stenfeldt C; Perez A; Delgado AH; Sharma MK; Rodriguez LL; Pattnaik B; Arzt J
    Transbound Emerg Dis; 2018 Apr; 65(2):e404-e415. PubMed ID: 29205858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating vaccination strategies to control foot-and-mouth disease: a country comparison study.
    Rawdon TG; Garner MG; Sanson RL; Stevenson MA; Cook C; Birch C; Roche SE; Patyk KA; Forde-Folle KN; Dubé C; Smylie T; Yu ZD
    Epidemiol Infect; 2018 Jul; 146(9):1138-1150. PubMed ID: 29785893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Point of view of KNMvD concerning foot and mouth disease marker vaccine].
    van Leeuwen JM
    Tijdschr Diergeneeskd; 2001 Sep; 126(17):585. PubMed ID: 11596520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.